Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
195.05
-1.58 (-0.80%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Quest Diagnostics Revenue
Quest Diagnostics had revenue of $2.90B in the quarter ending March 31, 2026, with 9.16% growth. This brings the company's revenue in the last twelve months to $11.28B, up 11.03% year-over-year. In the year 2025, Quest Diagnostics had annual revenue of $11.04B with 11.78% growth.
Revenue (ttm)
$11.28B
Revenue Growth
+11.03%
P/S Ratio
1.91
Revenue / Employee
$197,860
Employees
57,000
Market Cap
21.59B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 11.04B | 1.16B | 11.78% |
| Dec 31, 2024 | 9.87B | 620.00M | 6.70% |
| Dec 31, 2023 | 9.25B | -631.00M | -6.38% |
| Dec 31, 2022 | 9.88B | -905.00M | -8.39% |
| Dec 31, 2021 | 10.79B | 1.35B | 14.32% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IQVIA Holdings | 16.31B |
| Labcorp Holdings | 13.95B |
| Agilent Technologies | 7.07B |
| Illumina | 4.34B |
| IDEXX Laboratories | 4.30B |
| Mettler-Toledo International | 4.03B |
| Waters | 3.17B |
| Revvity | 2.86B |
DGX News
- 1 day ago - Quest Diagnostics Prices $500 Million of Senior Notes - PRNewsWire
- 6 days ago - These Analysts Boost Their Forecasts On Quest Diagnostics After Better-Than-Expected Earnings - Benzinga
- 7 days ago - Quest Diagnostics Earnings Call Transcript: Q1 2026 - Transcripts
- 7 days ago - Quest Diagnostics raises full-year forecast, posts strong quarter on testing demand - Reuters
- 7 days ago - Quest Diagnostics Reports First Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026 - PRNewsWire
- 12 days ago - City of Hope to Evaluate Quest Diagnostics' Haystack MRD® for Guiding Patient Management in Multiple Cancers - PRNewsWire
- 5 weeks ago - Quest Diagnostics to Release First Quarter Financial Results on April 21, 2026 - PRNewsWire
- 6 weeks ago - Quest Diagnostics Elects Timothy Wentworth, Former CEO of Walgreens Boots Alliance, Evernorth Health Services and Express Scripts, to Board of Directors - PRNewsWire